| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;70:883-888
© 2000 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Boston, Massachusetts, USA
b Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
Address reprint requests to Dr Shapira, Department of Cardiothoracic Surgery, Boston Medical Center, 88 E Newton St, Boston, MA 02118,
e-mail: oshapira{at}bu.edu
Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.
Background. Diltiazem is widely used to prevent radial artery spasm after coronary bypass grafting (CABG). However, recent in vitro and in vivo studies have shown that nitroglycerin is a superior conduit vasodilator compared to diltiazem. A clinical comparison of these agents in patients undergoing CABG has not been previously performed.
Methods. One hundred sixty-one consecutive patients undergoing isolated CABG with the radial artery were prospectively randomized to 24-hour intravenous infusion of nitroglycerin or diltiazem followed by 6-month treatment with a daily dose of isosorbide mononitrate (n = 84) or diltiazem CD (n = 77). Analyses were performed on "intention-to-treat" basis.
Results. Crossovers because of low cardiac output, complete heart block, or sinus bradycardia occurred in 5 patients in the diltiazem group and none in the nitroglycerin group (p = 0.05). Operative mortality (nitroglycerin, 1.2% versus diltiazem, 1.3%), major morbidity (14% versus 16%), perioperative myocardial infarction (1.2% versus 0%), peak serum creatinine phosphokinase MB fraction levels (27 versus 21 U), intensive care unit stay (34 ± 19 versus 38 ± 30 hours) and total hospital length of stay (4.7 ± 1.4 versus 4.7 ± 1.3 days) were similar (p = not significant for all). Cardiac pacing was required more often in the diltiazem group (28% versus 13%, p = 0.01). Follow-up longer than 2 months was available in 145 patients (90%). Follow-up mortality (nitroglycerin, 1.2%; diltiazem, 1.3%), myocardial infarction (6%, versus 5%), and reintervention (8% versus 6%) rates and average angina class (1.3 ± 0.7 versus 1.1 ± 0.4) were similar (p = not significant for all). Thallium stress test obtained in 117 patients showed abnormal perfusion in the radial artery territory in only 4 patients (3%), 2 in each group (p = not significant). Treatment with diltiazem was more costly ($16,340 versus $1,096).
Conclusions. Nitroglycerin is preferable to diltiazem for prevention of conduit spasm. Nitroglycerin is safe, effective, better tolerated, and less costly than diltiazem, and therefore, should be the agent of choice.
Related Article
Ann. Thorac. Surg. 2000 70: 888-889.
This article has been cited by other articles:
|
|
 |
|
  S. Attaran, L. John, and A. El-Gamel Clinical and Potential Use of Pharmacological Agents to Reduce Radial Artery Spasm in Coronary Artery Surgery Ann. Thorac. Surg., April 1, 2008; 85(4): 1483 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gongora and T. M. Sundt III Myocardial Revascularization with Cardiopulmonary Bypass Card. Surg. Adult, January 1, 2008; 3(2008): 599 - 632. [Full Text]
|
|
|
|
 |
|
 A. Patel, S. Asopa, and J. Dunning Should patients receiving a radial artery conduit have post-operative calcium channel blockers? Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gaudino, N. Luciani, G. Nasso, A. Salica, C. Canosa, and G. Possati Is postoperative calcium channel blocker therapy needed in patients with radial artery grafts? J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 532 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kerendi, M. E. Halkos, J. S. Corvera, H. Kin, Z.-Q. Zhao, M. Mosunjac, R. A. Guyton, and J. Vinten-Johansen Inhibition of myosin light chain kinase provides prolonged attenuation of radial artery vasospasm Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1149 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Emir, M. K. Gol, K. Ozisik, V. Bakuy, M. F. Sargon, S. Yavas, K. Cagli, K. Kilinc, and E. Sener Harvesting Techniques Affect the Integrity of the Radial Artery: An Electron Microscopic Evaluation Ann. Thorac. Surg., October 1, 2004; 78(4): 1319 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tabel, H. Hepaguslar, C. Erdal, H. Catalyurek, U. Acikel, Z. Elar, and O. Aslan Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Wijeysundera, W. S. Beattie, V. Rao, and J. Karski Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1496 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fazel, H. R. Mallidi, M. P. Pelletier, J. Y. Sever, G. T. Christakis, B. S. Goldman, and S. E. Fremes Radial artery use is safe in patients with moderate to severe left ventricular dysfunction Ann. Thorac. Surg., May 1, 2003; 75(5): 1414 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Drossos, I. K. Toumpoulis, D. G. Katritsis, J. P. A. Ioannidis, P. Kontogiorgi, E. Svarna, and C. E. Anagnostopoulos Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 330 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Woo and T. J. Gardner Myocardial Revascularization with Cardiopulmonary Bypass Card. Surg. Adult, January 1, 2003; 2(2003): 581 - 607. [Full Text]
|
|
|
|
|
|
P. Reddy, C. M. White, and J. Song Cost analysis of diltiazem and nitroglycerin for the prevention of coronary bypass conduit spasm Ann. Thorac. Surg., November 1, 2001; 72(5): 1798 - 1798. [Full Text] [PDF]
|
|
|
|
|
|
O. M. Shapira Cost analysis of diltiazem and nitroglycerin for the prevention of coronary bypass conduit spasm: Reply Ann. Thorac. Surg., November 1, 2001; 72(5): 1798 - 1799. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gaudino, F. Glieca, N. Luciani, F. Alessandrini, and G. Possati Clinical and Angiographic Effects of Chronic Calcium Channel Blocker Therapy Continued Beyond First Postoperative Year in Patients With Radial Artery Grafts: Results of a Prospective Randomized Investigation Circulation, September 18, 2001; 104(90001): I-64 - 67. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
